Company · CIK 1662524
AKCEA THERAPEUTICS, INC.
| CIK | 1662524 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2017-08-09 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-227403 | 2018-09-18 | 2018-09-18 | 1 | |
| 333-216949 | 2017-03-27 | 2017-07-14 | 7 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2018-09-18 | S-3ASRShelf registered | 333-227403 | 0001140361-18-038676 |
| 2017-07-14 | 424B4Final prospectus | 333-216949 | 0001047469-17-004565 |
| 2017-07-13 | EFFECTDeclared effective | 333-216949 | 9999999995-17-001805 |
| 2017-06-27 | S-1/AAmendment | 333-216949 | 0001047469-17-004270 |
| 2017-06-20 | S-1/AAmendment | 333-216949 | 0001047469-17-004108 |
| 2017-05-09 | S-1/AAmendment | 333-216949 | 0001047469-17-003287 |
| 2017-04-10 | S-1/AAmendment | 333-216949 | 0001047469-17-002433 |
| 2017-03-27 | S-1Registration filed | 333-216949 | 0001047469-17-001995 |
| 2016-05-06 | DRSDraft made public | 377-01321 | 0000912057-16-000575 |